This can allow for targeted prior authorization efforts to limit the impact on patients with T2DM who are appropriately receiving diabetes-approved GLP-1 RAs
your judgement
Central administration of GLP-1 and GIP decreases feeding in mice
Back Madsen, OD, Karlsen, C, Blume, N, et al (1995) 'Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia', Scandinavian Journal of Clinical and Laboratory Investigation Supplement , 220, 27-35
At Klinic, our emphasis on FDA-approved semaglutide products, such as Wegovy, rather than compounded equivalents, ensures quality, reliability, and proven effectiveness overseen by the FDA